Annual Accounts Receivable
$6.06 M
+$392.20 K+6.92%
31 December 2023
Summary:
Cytosorbents annual accounts receivable is currently $6.06 million, with the most recent change of +$392.20 thousand (+6.92%) on 31 December 2023. During the last 3 years, it has risen by +$897.80 thousand (+17.40%). CTSO annual accounts receivable is now at all-time high.CTSO Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$6.63 M
-$1.19 M-15.21%
30 September 2024
Summary:
Cytosorbents quarterly accounts receivable is currently $6.63 million, with the most recent change of -$1.19 million (-15.21%) on 30 September 2024. Over the past year, it has increased by +$454.00 thousand (+7.35%). CTSO quarterly accounts receivable is now -15.21% below its all-time high of $7.82 million, reached on 30 June 2024.CTSO Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTSO Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +6.9% | +7.3% |
| 3 y3 years | +17.4% | +26.6% |
| 5 y5 years | +53.6% | +92.4% |
CTSO Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +33.9% | -15.2% | +46.6% |
| 5 y | 5 years | at high | +53.6% | -15.2% | +92.4% |
| alltime | all time | at high | -15.2% |
Cytosorbents Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $6.63 M(-15.2%) |
| June 2024 | - | $7.82 M(+15.6%) |
| Mar 2024 | - | $6.77 M(+11.7%) |
| Dec 2023 | $6.06 M(+6.9%) | $6.06 M(-2.0%) |
| Sept 2023 | - | $6.18 M(-12.0%) |
| June 2023 | - | $7.02 M(+27.1%) |
| Mar 2023 | - | $5.53 M(-2.4%) |
| Dec 2022 | $5.66 M(+25.2%) | $5.66 M(+14.2%) |
| Sept 2022 | - | $4.96 M(-4.1%) |
| June 2022 | - | $5.17 M(+13.0%) |
| Mar 2022 | - | $4.58 M(+1.2%) |
| Dec 2021 | $4.52 M(-12.3%) | $4.52 M(-13.7%) |
| Sept 2021 | - | $5.24 M(-8.9%) |
| June 2021 | - | $5.75 M(+14.7%) |
| Mar 2021 | - | $5.02 M(-2.7%) |
| Dec 2020 | $5.16 M(+15.5%) | $5.16 M(-11.0%) |
| Sept 2020 | - | $5.80 M(+49.0%) |
| June 2020 | - | $3.89 M(-27.9%) |
| Mar 2020 | - | $5.40 M(+20.8%) |
| Dec 2019 | $4.47 M(+13.3%) | $4.47 M(+29.6%) |
| Sept 2019 | - | $3.45 M(-0.1%) |
| June 2019 | - | $3.45 M(+5.6%) |
| Mar 2019 | - | $3.27 M(-17.1%) |
| Dec 2018 | $3.94 M(+78.8%) | $3.94 M(+8.3%) |
| Sept 2018 | - | $3.64 M(+25.5%) |
| June 2018 | - | $2.90 M(+23.4%) |
| Mar 2018 | - | $2.35 M(+6.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $2.21 M(+53.9%) | $2.21 M(-6.1%) |
| Sept 2017 | - | $2.35 M(+14.2%) |
| June 2017 | - | $2.06 M(+18.9%) |
| Mar 2017 | - | $1.73 M(+20.8%) |
| Dec 2016 | $1.43 M(+120.9%) | $1.43 M(+1.9%) |
| Sept 2016 | - | $1.41 M(+48.9%) |
| June 2016 | - | $944.80 K(+24.3%) |
| Mar 2016 | - | $760.20 K(+17.2%) |
| Dec 2015 | $648.90 K(-20.8%) | $648.90 K(+17.3%) |
| Sept 2015 | - | $553.40 K(+10.5%) |
| June 2015 | - | $501.00 K(-25.5%) |
| Mar 2015 | - | $672.70 K(-17.9%) |
| Dec 2014 | $819.20 K(+80.8%) | $819.20 K(+45.8%) |
| Sept 2014 | - | $562.00 K(+70.1%) |
| June 2014 | - | $330.30 K(+0.9%) |
| Mar 2014 | - | $327.30 K(-27.7%) |
| Dec 2013 | $453.00 K(+774.5%) | $453.00 K(+133.6%) |
| Sept 2013 | - | $193.90 K(+130.6%) |
| June 2013 | - | $84.10 K(-26.6%) |
| Mar 2013 | - | $114.60 K(+121.2%) |
| Dec 2012 | $51.80 K(+43.5%) | $51.80 K(-0.2%) |
| Sept 2012 | - | $51.90 K(+19.6%) |
| June 2012 | - | $43.40 K(+9.0%) |
| Mar 2012 | - | $39.80 K(+10.2%) |
| Dec 2011 | $36.10 K(>+9900.0%) | $36.10 K(>+9900.0%) |
| Dec 2010 | $0.00 | $0.00(-100.0%) |
| Feb 2006 | - | $1900.00 |
FAQ
- What is Cytosorbents annual accounts receivable?
- What is the all time high annual accounts receivable for Cytosorbents?
- What is Cytosorbents annual accounts receivable year-on-year change?
- What is Cytosorbents quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Cytosorbents?
- What is Cytosorbents quarterly accounts receivable year-on-year change?
What is Cytosorbents annual accounts receivable?
The current annual accounts receivable of CTSO is $6.06 M
What is the all time high annual accounts receivable for Cytosorbents?
Cytosorbents all-time high annual accounts receivable is $6.06 M
What is Cytosorbents annual accounts receivable year-on-year change?
Over the past year, CTSO annual accounts receivable has changed by +$392.20 K (+6.92%)
What is Cytosorbents quarterly accounts receivable?
The current quarterly accounts receivable of CTSO is $6.63 M
What is the all time high quarterly accounts receivable for Cytosorbents?
Cytosorbents all-time high quarterly accounts receivable is $7.82 M
What is Cytosorbents quarterly accounts receivable year-on-year change?
Over the past year, CTSO quarterly accounts receivable has changed by +$454.00 K (+7.35%)